● The company shows low valuation levels, with an enterprise value at 0.37 times its sales.
Weaknesses
● Stock prices approach a strong long-term resistance in weekly data at EUR 10.98.
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company has insufficient levels of profitability.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
● For the past year, analysts have significantly revised downwards their profit estimates.
● The technical configuration over the long term remains negative on the weekly chart below the resistance level at 10.98 EUR